Amelioration of diabetic dyslipidemia by macrocyclic binuclear oxovanadium complex on streptozotocin induced diabetic rats
Diabetic dyslipidemia, the main causative factor for the progression of vascular complications in diabetes, is caused due to hyperglycemia and excess mobilisation of fatty acids. Recently we have reported on a novel macrocyclic binuclear oxovanadium (MBOV) complex synthesized by us with significant hypoglycemic efficacy and without any apparent toxicity on streptozotocin induced diabetic rats. In the present study, streptozotocin induced diabetic rats were treated with the vanadium complex (5 mg/kg body weight/day) for a period of 30 days and at the end of the treatment period the status of the lipid profile in the plasma, liver and kidney was evaluated. Also the fatty acid composition of liver and kidney were analysed by gas chromatography. The increased levels of lipid contents in plasma and tissues observed in diabetic rats were reverted back to near normal levels by the administration of the vanadium complex. Also the decreased levels of HDL cholesterol and increased levels of LDL cholesterol in plasma of diabetic rats were restored to near normal levels by the treatment with the vanadium complex. The altered fatty acid composition in liver and kidney were restored by the treatment. The results enhance the claim for the macrocyclic binuclear oxovanadium complex as a potent anti-diabetogenic drug.
Keywordshypolipidemic macrocyclic vanadium complex insulin-mimetic streptozotocin diabetes hyperlipidemia hypercholesterolemia dyslipidemia fatty acids
- MBOV complex
macrocyclic binuclear oxovanadium complex
hormone sensitive lipase
Unable to display preview. Download preview PDF.
- 6.Sakurai H, Tsuchiya K, Nukatsuka M, Sofue M, Kawada J: Insulin-like effect of vanadyl ion on streptozotocin diabetic rats. J Endocrinol 124: 451–459, 1990Google Scholar
- 17.Itaya K: A more sensitive and stable calorimetric determination of free fatty acids in plasma. J Lip Res 18: 663–665, 1977Google Scholar
- 19.Fiske CH, Subbarow Y: The colorimetric determination of phosphorus. J Biol Chem 66: 375–400, 1925Google Scholar
- 20.Burstein M, Scholnick HR: Precipitation of chylomicron and very low density protein from human serum with sodium lauryl sulphate. Life Sci 11: 177–184, 1972Google Scholar
- 21.Morrison WR, Smith LM: Preparations of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride methanol. J Lipid Res 5: 600–607, 1964Google Scholar
- 27.Starzl TE, Francavilla A, Halgrimson CG, Francavilla FR, Porter KA, Brown TH, Putnam CW: Surg Gynaecol Obstet 137: 179–199, 1973Google Scholar
- 32.Khan BA, Abraham A, Leelamma S: Hypoglycemic action of Murrya koenigii (curry leaf), Brassica juncea (mustard); mechanism of action. Ind J Biochem Biophys 32: 106–108, 1995Google Scholar
- 43.West KM: Hyperglycemia as a cause of long term complications. In: H. Keen, J. Jarret (eds). Complication of diabetes. Edward Arnold, London, 1982, pp 3–18Google Scholar
- 49.Jones DB, Carter RD, Haitas B, Maan JI: Low phospholipid arachidonic acid values in diabetic platelets. Br Med J 286: 173–175, 1983Google Scholar